Publication | Closed Access

Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: Synthesis and biological evaluation

NanomedicineMedicinal ChemistryDrug TargetingPolymer-drug ConjugateTargeted DeliveryMedicineNano-drug DeliveryUrsolic AcidAnti-cancer AgentTumor TargetingPharmacologyRadiation OncologyDrug DiscoveryDendrimeric Anticancer Prodrugs